Wednesday, November 10, 2021

U.S. v. Carter, 15 F.4th 26 (1st Cir. 2021), where the government successfully prosecuted a claim for fraud on the FDA, involving the concealment of unlicensed pharmaceutical manufacturing in guise of “pharmacy compounding.

https://cases.justia.com/federal/appellate-courts/ca1/19-1644/19-1644-2021-09-27.pdf?ts=1632776405 

No comments: